Injectibles

How to Decide Exactly Where to Get Fillers and Botox

Your forehead isn't the only spot you can get an injectable. Here's what you need to know about filler and Botox injection sites — both well-established and newly available, according to Shape.

Injectibles

A New Era for Fat-Based Injectables in Body Contouring

A new fat-based injectable is reshaping non-surgical body contouring. Plastic Surgery Practice examines the science and clinical adoption of alloClae with Tiger Aesthetics President Caroline Van Hove and Dr David Shafer.

All

Long-Term Data Shows Sustained Skin Clearance in Psoriasis with FDA-Approved Biologic

Study results presented at EADV 2025 show nearly half of initial complete responders maintained clearance over four years.

Galderma Reports Positive Results for Facial Volume Loss Tied to Medication-Driven Weight Loss

by Alyx Arnett | Jul 18, 2025 | Injectibles | 0

The phase IV trial evaluated outcomes of Sculptra plus Restylane Lyft or Contour in patients with facial volume loss due to weight loss medications.

Patient Perspective as Clinical Data: Dr Steven Dayan on PROs and Aesthetic Outcomes

by Alison Werner | Jul 15, 2025 | Botox, Patient Relations, Research | 0

Dr Steven Dayan discusses how patient-reported outcomes (PROs) are shaping clinical research, regulatory standards, and patient care in aesthetic medicine.

Skinvive by Juvéderm Targets Neck Lines in New FDA Filing

by Alyx Arnett | Jun 30, 2025 | Injectibles | 0

If approved, Skinvive by Juvéderm will be the first hyaluronic acid injectable treatment option aiming to reduce neck lines.

Health Canada Authorizes Clinical Trial for Cellulose-Based Dermal Filler

by Alyx Arnett | Jun 16, 2025 | Injectibles | 0

The cellulose-based dermal filler has received Health Canada authorization to begin clinical trials evaluating its safety and performance in tissue augmentation.

Health Canada Approves Radiesse for Décolleté Wrinkles

by Alyx Arnett | Jun 6, 2025 | Injectibles | 0

Regulatory approval allows clinicians to use the biostimulatory filler to treat moderate wrinkles in the chest area.

Where Non-Surgical Aesthetic Spending Is Headed: Inside the $17.5 Billion Aesthetic Shift

by Alison Werner | Jun 3, 2025 | Aesthetics, Injectibles | 0

Guidepoint Qsight’s Erik Haines breaks down the drivers behind 2024’s $17.5 billion in non-surgical aesthetic spending and what it signals for the future of the industry.

How Evolysse Could Change the HA Filler Market: Insights from Dr Rami Batniji

by Alison Werner | May 13, 2025 | Injectibles | 0

Dr Rami Batniji discusses how Evolysse’s cold technology manufacturing process may offer clinical advantages over traditional hyaluronic acid fillers.

Understanding the Rise in Male Facial Plastic Surgery: Insights from AAFPRS President Patrick Byrne

by Alison Werner | May 13, 2025 | Hair Transplant, Injectibles, Mini Facelifts | 0

AAFPRS President Dr. Patrick Byrne discusses the growing interest in facial cosmetic procedures among male patients and how private practices can adapt to meet their evolving needs.

New Revanesse Renew+ Skin-boosting Injection Debuts in Canada

by Alyx Arnett | May 7, 2025 | Injectibles | 0

The product is designed to provide long-lasting hydration to improve skin quality from the inside out.

New Short-Term Botox-Like Treatment Moves Closer to FDA Review

by Alyx Arnett | Apr 25, 2025 | Injectibles | 0

The neurotoxin is characterized by a rapid onset of action as early as eight hours after administration and a shorter duration of effect of two to three weeks.

Evolysse Form and Smooth Injectable HA Gels Hit Market

by Alison Werner | Apr 17, 2025 | Injectibles | 0

Evolus launched its Evolysse Form and Evolysse Smooth injectable HA gels on April 18, following a national webcast and early access program involving over 1,000 aesthetic practices.

A New Player in the Toxin Market: Dr Donald Yoo on Letybo’s U.S. Prospects

by Alison Werner | Mar 25, 2025 | Botox | 0

Beverly Hills facial plastic surgeon Donald Yoo, MD, shares insights on Letybo’s clinical performance, its potential in the U.S. market, and how platforms like Persana are changing the injectable landscape.

CaHA Injectable for Facial Use Gains Regulatory Approval in China

by Alyx Arnett | Mar 24, 2025 | Injectibles | 0

The approval makes it the first calcium hydroxylapatite microsphere injectable product approved in China for facial soft tissue augmentation, according to the company.

Galderma to Share New Data on Injectables and Weight Loss–Related Facial Changes

by Alyx Arnett | Mar 21, 2025 | Injectibles | 0

The company will present findings on Relfydess, Sculptra, and Restylane, along with results from an international survey on aesthetic impacts of medication-driven weight loss.